SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-040216
Filing Date
2020-12-01
Accepted
2020-12-01 16:15:07
Documents
2
Period of Report
2020-11-27
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea130392-8k_180lifesciences.htm 8-K 26316
2 LETTER OF WITHUMSMITH+BROWN, PC REGARDING CHANGE IN CERTIFYING ACCOUNTANT. ea130392ex16-1_180lifescien.htm EX-16.1 2002
  Complete submission text file 0001213900-20-040216.txt   29692
Mailing Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019
Business Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019 212-319-5555
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 201361025
SIC: 2834 Pharmaceutical Preparations